Improving the Outcome for Children With Cancer: The Costs of Risk Aversion

Dr. Adamson discusses the role of the IGF-1 pathway in cancer and the risks associated with cancer, cancer treatment, and cancer research in children. Presented by Dr. Peter C. Adamson, Professor of Pediatrics & Pharmacology, Children's Hospital of Philadelphia; Chair, Children's Oncology Group. (2016)